Bora Pharmaceuticals Co., Ltd. (BORAY)

Market Cap	1.80B -35.5%
Revenue (ttm)	605.51M +9.1%
Net Income	94.94M -22.6%
EPS	0.50 -42.1%
Shares Out	n/a
PE Ratio	19.01
Forward PE	19.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,000
Average Volume	942
Open	3.200
Previous Close	n/a
Day's Range	3.200 - 3.200
52-Week Range	3.170 - 5.000
Beta	0.72
RSI	31.73
Earnings Date	May 12, 2026

About Bora Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Country: Taiwan
• Stock Exchange: OTCMKTS
• Ticker Symbol: BORAY

Financial Performance

In 2025, Bora Pharmaceuticals's revenue was 19.01 billion, an increase of 9.11% compared to the previous year's 17.43 billion. Earnings were 2.98 billion, a decrease of -22.61%.

Financial numbers in TWD